Sponsor:
UCLA
Code:
NCT05641961
Conditions
Childhood Cancer
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Interventions
Survivorship mobile application
Questionnaires
Brief summary:
Conditions
Childhood Cancer
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Study ID
NCT05641961
Start date
Nov 29, 2022
Status verified date
Jul, 2025
Completion date
Apr 30, 2026
Anticipated
Primary completion date
Apr 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
30 participants
Anticipated
Intervention Model
Single group
Primary purpose
Health Services Research
Arms
experimental: Survivorship Mobile Application
Interventions
Survivorship mobile application
Questionnaires
Primary outcome measure
Central contacts
Locations
University of California, San Francisco
Recruiting
San Francisco, California, United States, 94143
Contacts
Principal Investigator:
Robert Goldsby, MD
Sponsor
University of California, San Francisco
Last update posted
Jul 23, 2025
Last verified
Jul, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-07-23.